原核质粒pGEX-4T-2-PLEKHQ1及真核质粒pCMV-Myc-PLEKHQ1的构建与蛋白表达
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Construction of pGEX-4T-2-PLEKHQ1 prokaryotic plasmid and pCMV-Myc-PLEKHQ1 eukaryotic plasmid and their protein expression
  • 作者:陆琤 ; 周晨辰 ; 张鹏飞 ; 张硌
  • 英文作者:LU Cheng;ZHOU Chen-chen;ZHANG Peng-fe;Department of Medical Engineering, No307 Hospital of PLA;
  • 关键词:基因PLEKHQ1 ; pGEX-4T-2载体 ; pCMV-Myc载体 ; 重组质粒 ; 表达
  • 英文关键词:PLEKHQ1;;pGEX-4T-2 vector;;pCMV-Myc vector;;Recombinant plasmid;;Expression
  • 中文刊名:YXZB
  • 英文刊名:China Medical Equipment
  • 机构:军事医学科学院附属医院医学工程科;
  • 出版日期:2015-05-15
  • 出版单位:中国医学装备
  • 年:2015
  • 期:v.12;No.129
  • 基金:国家自然科学基金(31400739)“PH结构域蛋白PLEKHQ1协调巨噬细胞迁移与激活的机制研究”;; 北京市自然科学基金(5144033)“PH结构域蛋白PLEKHQ1调控巨噬细胞激活及迁移的机制研究”
  • 语种:中文;
  • 页:YXZB201505002
  • 页数:4
  • CN:05
  • ISSN:11-5211/TH
  • 分类号:10-13
摘要
目的:构建基因PLEKHQ1的原核质粒及真核质粒。方法:全长编码基因PLEKHQ1的聚合酶链反应(PCR)产物经Eco RⅠ和Kpn1双酶切后,分别与双酶切后的载体pGEX-4T-2及载体pCMV-Myc相连,在pGEX-4T-2-PLEKHQ1转化E.coli DH5α提取质粒后,转化E.coli BL21中诱导GST-Q1融合蛋白表达,利用谷胱甘肽琼脂糖4B纯化诱导的融合蛋白;而pCMVMyc-PLEKHQ1则瞬转至293TX细胞;用蛋白质印迹法(Western blot)检测GST-Q1和Myc-Q1融合蛋白表达。结果:将获得的重组质粒进行双酶切鉴定,得到约1500 bp的目的片段,符合预计大小。质粒经测序分析正确后,Western blot检测到诱导及纯化后的GST-Q1和转染293TX后的Myc-Q1蛋白。结论:成功构建的pGEX-4T-2-PLEKHQ1和pCMV-Myc-PLEKHQ1重组质粒,为深入研究PLEKHQ1功能奠定良好的基础。
        Objective: To construct prokaryotic plasmid and eukaryotic plasmid of PLEKHQ1 gene. Methods: The PCR product of the PLEKHQ1 coding sequence, which was digested with Eco R1 and Kpn1 restriction enzymes, was taped into the plasmid pGEX-4T-2 and pCMVMyc. Then pGEX-4T-2-PLEKHQ1 was transformed into E.coli DH5α and plasmid DNA was extracted. After that, the expression of GST-Q1 fusion protein was induced in BL21 and was purified by Glutathione Sepharose 4B. While the pCMV-Myc-PLEKHQ1 was transfected into TX cells. The expression of both GST-Q1 and Myc-Q1 was detected by Western blot. Results: The restriction enzyme digestion showed target fragment of 1500 bp, which was as expected. The recombinant plasmid was sequenced right and GST-Q1 protein and Myc-Q1 protein could be detected by Western blot. Conclusion: The recombinant prokaryotic plasmid and eukaryotic expression plasmid were successfully constructed, which laid a foundation for further research for PLEKHQ1.
引文
[1]Strausberg RL,Feingold EA,Grouse LH,et al.Generation and initial analysis of more than 15,000full-length human and mouse cD NA sequences[J].Proc Natl Acad Sci USA,2002,99(26):16899-16903.
    [2]Ota T,Suzuki Y,Nishikawa T,et al.Complete sequencing and characterization of 21,243 fulllength human c DNAs[J].Nat Genet,2004,36(1):40-45.
    [3]Antoshechkin A,Olalde J,Magarici M.Analysis of effects of the herbal preparation Circulat on gene expression levels in cultured human fibroblasts[J].Phytother Res,2007,21:777-789.
    [4]Choudhary C,Kumar C,Gnad F,et al.Lysine acetylation targets protein complexes and co-regulates major cellular functions[J].Science,2009,325(5942):834-840.
    [5]Oláh J,Vincze O,Virók D,et al.Interactions of pathological hallmark proteins:tubulin polymerization promoting protein/p25,betaamyloid,and alpha-synuclein[J].J Biol Chem,2011,286(39):34088-34100.
    [6]Povlsen LK,Beli P,Wagner SA,et al.Systemswide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNAdamage bypass[J].Nat Cell Biol,2012,14(10):1089-1098.
    [7]Wagner SA,Beli P,Weinert BT,et al.A proteome-wide,quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles[J].Mol Cell Proteomics,2011,10(10):013284.
    [8]Zhang L,Tie Y,Tian C,et al.CKIP-1recruits nuclear ATM partially to the plasma membrane through interaction with ATM[J].Cell Signal,2006,18(9):1386-1395.
    [9]Bosc DG,Graham KC,Saulnier RB,et al.Identification and charac-terization of CKIP-1,a novel pleckstrin homology domaincontaining protein that interacts with protein kinase CK2[J].J Biol Chem,2000,275(19):14295-14306.
    [10]Tokuda E,Fujita N,Oh hara T,et al.Casein kinase 2-interacting protein-1,a novel Akt pleckstrin homology domain-interacting protein,down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo[J].Cancer Res,2007,67(20):9666-9676.